\[1\]Zamirian M,Tavassoli M,Aghasadeghi K.Corrected QT interval and QT dispersion in cirrhotic patients before and after liver transplantation\[J\].Arch Iran Med,2012,15(6):375.
\[2\]Lentine KL,Costa SP,Weir MR,et al.Cardiac disease evaluation and management among kidney and liver transplantation candidates:a scientific statement from the American Heart Association and the American College of Cardiology Foundation\[J\].J Am Coll Cardiol,2012,60(5):434.
\[3\]Xu ZD,Xu HT,Yuan HB,et al.Postreperfusion syndrome during orthotopic liver transplantation:a single\|center experience\[J\].Hepatobiliary Pancreat Dis Int,2012,11(1):34\|39.
\[4\]Leithead JA,Tariciotti L,Gunson B,et al.Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury\[J\].Am J Transplant,2012,12(4):965\|975.
\[5\]Giakoustidis A,Cherian TP,Antoniadis N,et al.Combined cardiac surgery and liver transplantation:three decades of worldwide results\[J\].J Gastrointestin Liver Dis,2011,20(4):415\|421.
\[6\]吴东进,徐益萍,吴蔚宇,等.七氟烷吸入诱导与静脉诱导麻醉在心脏手术患儿中的比较\[J\].上海医学,2010,33(6):521\|524.
\[7\]Crystal GJ,Malik G,Yoon SH,et al.Isoflurane late preconditioning against myocardial stunning is associated with enhanced antioxidant defenses\[J\].Acta Anaesthesiol Scand,2012,56(1):39\|47.
\[8\]Bignami E,Greco T,Barile L,et al.The effect of isoflurane on survival and myocardial infarction:a meta\|analysis of randomized controlled studies\[J\].J Cardiothorac Vasc Anesth,2013,27(1):50\|58.
|